Sensitive and selective liquid chromatography-tandem mass spectrometry method for the determination of metoclopramide in human plasma: Application to a bioequivalence study

Biomedical Chromatography

Volumn 24, Issue 9, 2010, Pages 1006-1014

  Inamadugu, Jaswanth Kumar ^a,b   Damaramadugu, Rajasekhar ^a,b   Mullangi, Ramesh ^c   Ponneri, Venkateswarlu ^a  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b Wellquest Clinical Research Laboratories   (India)

^c 2nd Stage   (India)

Author keywords

Human plasma; LC MS MS; Method validation; Metoclopramide; Pharmacokinetics

Indexed keywords

HIGH PRESSURE LIQUID CHROMATOGRAPHY; PLASMA (HUMAN); SOLVENT EXTRACTION;

BIOEQUIVALENCE STUDY; HUMAN PLASMAS; INTERNAL STANDARDS; LC-MS-MS; LC.MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; METHOD VALIDATIONS; METOCLOPRAMIDE; SELECTIVE LIQUID CHROMATOGRAPHY;

MASS SPECTROMETRY;

ACETONITRILE; AMMONIUM ACETATE; METOCLOPRAMIDE; TRAMADOL;

ACCURACY; ARTICLE; BIOEQUIVALENCE; DRUG DETERMINATION; DRUG STABILITY; FLOW RATE; FOOD AND DRUG ADMINISTRATION; FREEZE THAWING; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; PLASMA; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 77957205595     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1401     Document Type: Article

References (23)

1. Albani F, Riva R, Contin M and Baruzzi A. Liquid chromatographic analysis of metoclopramide with fluorescence detection in cirrhotic patients. Biomedical Chromatography 1987; 2: 135-136. (Pubitemid 18060718)
2. Albibi R and McCallum RW. Metoclopramide: pharmacology and clinical application. Annals of International Medicine 1983; 98: 86-95.
3. Bateman DN, Kahn C, Mashiter K and Davies DS. Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. British Journal of Clinical Pharmacology 1978; 6: 401-407.
4. Buss DC, Hutchings AD, Scott S and Routledge PA. A rapid liquid chromatographic method for the determination of metoclopramide in human plasma. Therapeutic Drug Monitoring 1990; 12: 293-296. (Pubitemid 20150898)
5. Dams R, Huestis MA, Lambert WE and Murphy CM. Matrix effect in bioanalysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. Journal of American Society for Mass Spectrometry 2003; 14: 1290-1294.
6. Desta Z, Wu GM, Morocho AM and Flockhart DA. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metabolism and Disposition 2002; 30: 336-343. (Pubitemid 34175027)
7. de Jong AP, Wittebrood AJ, du Chatinier WM and Bron J. Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction Journal of Chromatography 1987; 419: 233-242.
8. Fairhead AP, Brooks SG, Butterworth KR and Mangham BA. An automated high-performance liquid chromatographic trace enrichment method for the determination of metoclopramide in serum and its application to a bioequivalence human volunteer study. Food and Chemical Toxicology 1989; 27: 341-345.
9. Graffner C, Lagerstrom PO, Lundborg P and Ronn O. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography. British Journal of Clinical Pharmacology 1979; 8: 469-474.
10. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA and Heel RC. Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 1983; 25: 451-494. (Pubitemid 13130833)
11. Horiuchi T, Minetomatsu K, Mizuno Y, Sekiya T and Hamamoto K. Residue analysis of metoclopramide in bovine and swine tissues by HPLC and administration experiment. Shokuhin Eiseigaku Zasshi 2006; 47: 258-262.
12. Hubert Ph, Chiap P, Crommen J, Boulanger B, Chapuzet E, Mercier N, Bervoas-Martin S, Chevalier P, Grandjean D, Lagorce P, Lallier M, Laparra MC, Laurentie M and Nivet JC. The SFSTP guide on the validation of chromatographic methods for drug bioanalysis Washington conference to the laboratory. Analytica Chimica Acta 1999; 391: 135-148.
13. Jones RD, Blanton CD and Bowen JM. Identification of metoclopramide metabolites in the urine of cattle by gas chromatography-mass spectrometry and high-performance liquid chromatography-photodiode array detection. Veterinary Research Communications 1993; 17: 387-396. (Pubitemid 24084895)
14. Lamparczyk H, Chmielewska A, Konieczna L, Plenis A and Zarzycki PK. RP-HPLC method with electrochemical detection for the determination of metoclopramide in serum and its use in pharmacokinetic studies. Biomedical Chromatography 2001; 15: 513-517.
15. Lee HW, Ji HY, Kim HY, Park ES, Lee KC and Lee HS. Determination of metoclopramide in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry. Journal of Chromatography B 2009; 877: 1716-1720.
16. Popovic C. High-pressue liquid chromatographic method for the determination of metoclopramide in serum, urine, and saliva, with a pharmacokinetic study in patients. Therapeutic Drug Monitoring 1984; 6: 77-82.
17. Riggs KW, Szeitz A, Rurak DW, Mutlib AE, Abbott FS and Axelson JE. Determination of metoclopramide and two of its metabolites using a sensitive and selective gas chromatographic-mass spectrometric assay. Journal of Chromatography B 1994; 660: 315-325.
18. Riley CM. Determination of metoclopramide in plasma by reverse-phase ion-pair high- performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 1984; 2: 81-89. (Pubitemid 14000034)
19. Takahashi H, Ogata H, Echizen H and Ishizaki T. Determination of metoclopramide and its glucuronide and sulphate conjugates in human biological fluids (plasma, urine and bile) by ion-pair high-performance liquid chromatography. Journal of Chromatography B 1987; 419: 243-251.
20. US DHHS, FDA, CDER. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001. Available at: http://www/fda.gov/cder/ guidance/index.htm
21. US DHHS, FDA, CDER. Guidance for Industry: Bioequivalence Guidance. US Department of Health and Human Services, Food and Drug Administration, Center for Veterinary Medicine, 2006. Available at: http://www/fda.gov/cder/guidance/ index.htm
22. Vlase L, Leucutta A, Farcau D and Nanulescu M. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers. Biopharmaceutics Drug Disposition 2006; 27: 285-289.
23. Zaki NM, Mortada ND, Awad GA and Abd ElHady SS. Rapid on-set intranasal delivery of metoclopramide hydrochloride Part II. Safety of various absorption enhancers and pharmacokinetic evaluation. International Journal of Pharmaceutics 2006; 327: 97-103.